138 related articles for article (PubMed ID: 22381571)
1. Incidence of prostate cancer in Lithuania after introduction of the Early Prostate Cancer Detection Programme.
Smailyte G; Aleknaviciene B
Public Health; 2012 Dec; 126(12):1075-7. PubMed ID: 22381571
[TBL] [Abstract][Full Text] [Related]
2. Cancer surveillance using registry data: Results and recommendations for the Lithuanian national prostate cancer early detection programme.
Gondos A; Krilaviciute A; Smailyte G; Ulys A; Brenner H
Eur J Cancer; 2015 Aug; 51(12):1630-7. PubMed ID: 26044924
[TBL] [Abstract][Full Text] [Related]
3. Changing Incidence and Stage Distribution of Prostate Cancer in a Lithuanian Population-Evidence from National PSA-Based Screening Program.
Patasius A; Smailyte G
Int J Environ Res Public Health; 2019 Dec; 16(23):. PubMed ID: 31816821
[TBL] [Abstract][Full Text] [Related]
4. Suicide risk among prostate cancer patients before and after the implementation of prostate-specific antigen-based prostate screening in Lithuania in 2006.
Patasius A; Kaceniene A; Ulys A; Stukas R; Smailyte G
Eur J Cancer Prev; 2021 Jan; 30(1):103-107. PubMed ID: 32039931
[TBL] [Abstract][Full Text] [Related]
5. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
Tonita JM; Skarsgard D; Muhajarine N
Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine.
Patasius A; Innos K; Barchuk A; Ryzhov A; Leja M; Misins J; Yaumenenka A; Smailyte G
BMJ Open; 2019 Oct; 9(10):e031856. PubMed ID: 31601600
[TBL] [Abstract][Full Text] [Related]
7. An analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986-2020.
Everatt R; Gudavičienė D
BMC Public Health; 2022 Sep; 22(1):1812. PubMed ID: 36151551
[TBL] [Abstract][Full Text] [Related]
8. Educational inequalities in cancer incidence and mortality in Lithuania: a record linkage study.
Smailyte G; Jasilionis D; Ambrozaitiene D; Stankuniene V
Cancer Epidemiol; 2012 Oct; 36(5):e279-83. PubMed ID: 22705124
[TBL] [Abstract][Full Text] [Related]
9. PSA screening and deaths from prostate cancer after diagnosis--a population based analysis.
Wachtel MS; Nelius T; Haynes AL; Dahlbeck S; de Riese W
Prostate; 2013 Sep; 73(12):1365-9. PubMed ID: 23649537
[TBL] [Abstract][Full Text] [Related]
10. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971-1995.
Post PN; Kil PJ; Crommelin MA; Schapers RF; Coebergh JW
Eur J Cancer; 1998 Apr; 34(5):705-9. PubMed ID: 9713278
[TBL] [Abstract][Full Text] [Related]
11. Number of Screening Rounds and Postscreening Prostate Cancer Incidence: Results from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer Study.
Pakarainen T; Raitanen J; Talala K; Taari K; Kujala P; Tammela TL; Auvinen A
Eur Urol; 2016 Sep; 70(3):499-505. PubMed ID: 27210461
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer mortality in the Finnish randomized screening trial.
Kilpeläinen TP; Tammela TL; Malila N; Hakama M; Santti H; Määttänen L; Stenman UH; Kujala P; Auvinen A
J Natl Cancer Inst; 2013 May; 105(10):719-25. PubMed ID: 23479454
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer mortality in areas with high and low prostate cancer incidence.
Stattin P; Carlsson S; Holmström B; Vickers A; Hugosson J; Lilja H; Jonsson H
J Natl Cancer Inst; 2014 Mar; 106(3):dju007. PubMed ID: 24610909
[TBL] [Abstract][Full Text] [Related]
14. Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden.
Jonsson H; Holmström B; Duffy SW; Stattin P
Int J Cancer; 2011 Oct; 129(8):1881-8. PubMed ID: 21154740
[TBL] [Abstract][Full Text] [Related]
15. The role of increasing detection in the rising incidence of prostate cancer.
Potosky AL; Miller BA; Albertsen PC; Kramer BS
JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
[TBL] [Abstract][Full Text] [Related]
16. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
17. Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
Carlsson S; Assel M; Ulmert D; Gerdtsson A; Hugosson J; Vickers A; Lilja H
Eur Urol; 2017 Jan; 71(1):46-52. PubMed ID: 27084245
[TBL] [Abstract][Full Text] [Related]
18. Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.
Coldman AJ; Phillips N; Pickles TA
CMAJ; 2003 Jan; 168(1):31-5. PubMed ID: 12515782
[TBL] [Abstract][Full Text] [Related]
19. PSA measurement and prostate cancer--overdiagnosis and overtreatment?
Breidablik HJ; Meland E; Aakre KM; Førde OH
Tidsskr Nor Laegeforen; 2013 Sep; 133(16):1711-6. PubMed ID: 24005707
[TBL] [Abstract][Full Text] [Related]
20. [Prostatic cancer in the Grand Duchy of Luxembourg. Role of PSA].
Lamy S; Hein T; Wilmart JF; Capesius C; Scheiden R; Gilson G; Humbel RL
Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):11-23. PubMed ID: 9868829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
